PROM1 and cancer: Specifically, membrane glycoprotein CD133, discovered in 1997, alone or in combination with other markers, is one of the most well-characterized stem cells (SCs)-associated antigens in various tissues and in cancer stem cells (CSCs) from different neoplasms, including vascular tumors [19,20,21,22,23,24,25,26].